# OnCo record samsung-bioepis (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/samsung-bioepis/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "samsung-bioepis" ;
  schema:name "Samsung Bioepis"@en ;
  schema:description "Samsung Bioepis develops biosimilars of trastuzumab, bevacizumab and other antibodies, made by its parent Samsung Biologics at Songdo."@en ;
  schema:url <https://onco.cc/companies/samsung-bioepis/>, <https://www.samsungbioepis.com> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.samsungbioepis.com> ;
  onco:tag "manufacturing-wave" ;
  schema:addressCountry "KR" ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/colorectal/> ;
  onco:technologies <https://onco.cc/technologies/biosimilar-manufacturing/>, <https://onco.cc/technologies/monoclonal-antibody-manufacturing/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/bevacizumab/> .